Stock Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Non-vested Restricted Stock Units Activity

The table below summarizes the restricted stock unit ("RSU") activity for the three months ended March 31, 2023:

				Weighted-
				Average
	Shares			Fair Value
Unvested RSUs—December 31, 2022		31,288,688		$	10.34
Granted		11,845,227			8.88
Vested		(3,458,937	)		10.27
Forfeited		(664,230	)		10.30
Unvested RSUs—March 31, 2023		39,010,748			9.90

Summary of Share-based Compensation Arrangements by Share-based Payment Award

The table below summarizes the option activity for the three months ended March 31, 2023:

						Weighted-
						Average
				Weighted-		Remaining		Aggregate
				Average		Contractual		Intrinsic
				Exercise		Life		Value
	Shares			Price		(in years)		(in thousands)
Options outstanding—December 31, 2022		45,249,260		$	2.99		4.9	$	258,470
Exercised		(3,214,093	)		2.56
Forfeited and canceled		(454,982	)		7.22
Options outstanding—March 31, 2023		41,580,185		$	2.97		4.8	$	249,303
Options exercisable—March 31, 2023		38,959,492		$	2.81		4.6	$	239,876
Options vested and expected to vest—March 31, 2023		41,441,319		$	2.96		4.8	$	248,857

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Stock-Based Compensation—Stock-based compensation expense has been recorded in the accompanying condensed consolidated statements of operations and comprehensive income as follows for the three months ended March 31, 2023 and 2022 (in thousands):

	For the Three Months Ended
	March 31,
	2023		2022
Cost of revenues	$	1,901	$	849
Research and development		5,875		3,530
Sales and marketing		7,258		4,830
General and administrative		14,200		14,435
Total stock-based compensation expense	$	29,234	$	23,644

Ccc2021 Employee Stock Purchase Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of ESPP purchase rights sold during the three months ended March 31, 2023 was estimated using the Black-Scholes option pricing model with the following assumptions:

Expected term (in years)	0.5
Expected volatility	51%
Expected dividend yield	0%
Risk-free interest rate	2.5%